NCT06942533 Effect of Visual Feedback From the SpiroGym Mobile Application
| NCT ID | NCT06942533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | General University Hospital, Prague |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-05-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The previous pilot study showed that two weeks of intensive expiratory muscle strength training (EMST) with SpiroGym was sufficient to significantly improve voluntary peak cough flow (PCF). The improvement was quantitatively comparable to that reported in other intensive EMST studies of longer duration. To explain this rapid improvement, we considered the potential contribution of SpiroGym's visual feedback. We assumed that real-time visual feedback increased training effort compared with conventional EMST performed without immediate feedback. The aim of this study is to evaluate the effect of visual feedback provided by the SpiroGym mobile application on performance during expiratory muscle strength training in patients with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Parkinsons disease * Stable dopaminergic medication (stable dose for at least 1 month) Exclusion Criteria: * Other neurological disorders * Significant cognitive impairment * Major psychiatric disorder * History of head or neck cancer or previous surgical interventions in the neck region. * Illness during the study period
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06942533 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06942533 currently recruiting?
Yes, NCT06942533 is actively recruiting participants. Contact the research team at martin.srp@vfn.cz for enrollment information.
Where is the NCT06942533 trial being conducted?
This trial is being conducted at Prague, Czechia, Prague, Czechia.
Who is sponsoring the NCT06942533 clinical trial?
NCT06942533 is sponsored by General University Hospital, Prague. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.